A meta-analysis in localized bladder cancer found that PD-L1 expression in tumor cells, as assessed by immunohistochemistry (IHC) and different monoclonal antibodies, was correlated to a poorer clinical outcome in BC, but only two studies specifically looked at HR-NMIBC [23]. The gene discussed is CD274; the disease is neoplasm.